REVOTAR Biopharmaceuticals' Other Investors

REVOTAR Biopharmaceuticals raised a round of funding on , .

Revotar develops anti-inflammatory drugs for inflammatory indications such as psoriasis, acute lung injury (ALI) and chronic obstructive pulmonary disease (COPD).…

Articles about REVOTAR Biopharmaceuticals' Other Investors: